Pasithea Change In Working Capital from 2010 to 2025

KTTAW Stock  USD 0.02  0  9.90%   
Pasithea Therapeutics Change In Working Capital yearly trend continues to be fairly stable with very little volatility. Change In Working Capital is likely to outpace its year average in 2025. Change In Working Capital is the difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities. View All Fundamentals
 
Change In Working Capital  
First Reported
2010-12-31
Previous Quarter
-1.5 M
Current Value
-1.4 M
Quarterly Volatility
672.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pasithea Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pasithea Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 783 K, Other Operating Expenses of 9.9 M or Total Operating Expenses of 15 B, as well as many indicators such as Price To Sales Ratio of 36.39, Dividend Yield of 83.34 or PTB Ratio of 2.0E-4. Pasithea financial statements analysis is a perfect complement when working with Pasithea Therapeutics Valuation or Volatility modules.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Latest Pasithea Therapeutics' Change In Working Capital Growth Pattern

Below is the plot of the Change In Working Capital of Pasithea Therapeutics Corp over the last few years. It is the difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities. Pasithea Therapeutics' Change In Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pasithea Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Change In Working Capital10 Years Trend
Pretty Stable
   Change In Working Capital   
       Timeline  

Pasithea Change In Working Capital Regression Statistics

Arithmetic Mean(86,911)
Coefficient Of Variation(773.61)
Mean Deviation355,063
Median2,295
Standard Deviation672,347
Sample Variance452.1B
Range3.1M
R-Value(0.26)
Mean Square Error452.3B
R-Squared0.07
Significance0.34
Slope(36,295)
Total Sum of Squares6.8T

Pasithea Change In Working Capital History

2025-1.4 M
2024-1.5 M
20231.6 M
2022-138.4 K
2021111.2 K

About Pasithea Therapeutics Financial Statements

Pasithea Therapeutics investors use historical fundamental indicators, such as Pasithea Therapeutics' Change In Working Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pasithea Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change In Working Capital-1.5 M-1.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pasithea Stock Analysis

When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.